Overview

Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Tolerability of Acthar for the Treatment of Multiple Sclerosis Relapses (TAMS)
Phase:
N/A
Details
Lead Sponsor:
Ohio State University
OhioHealth
Treatments:
Adrenocorticotropic Hormone